ArticleFrontiers in endocrinology2026
Development and validation of a prediction model for psychological distress in patients with differentiated thyroid cancer undergoing ¹³¹I therapy.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate a risk prediction model for psychological distress in patients with differentiated thyroid cancer (DTC) undergoing ¹³¹I therapy. Methods: A total of 247 DTC patients who received ¹³¹I therapy at a tertiary Grade A hospital in Taiyuan between May and December 2025 were enrolled. Independent risk factors for psychological distress were identified to construct the model. Model performance was evaluated using receiver operating characteristic (ROC) curves, the Hosmer-Lemeshow test, and calibration curves. Results: Multivariate logistic regression identified poor sleep quality, thyroid-stimulating hormone (TSH) stimulation, pulmonary metastasis, social support, radiation exposure concerns, and lower serum 25-hydroxyvitamin D levels as independent risk factors (all Conclusion: This internally validated model is a promising tool for predicting psychological distress in DTC patients undergoing ¹³¹I therapy. However, external validation in larger, multicenter cohorts is necessary before routine clinical use can be recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.